Live from the NIH registry
Studies recruiting near Elkhart right now
Top 25 of 110 recruiting studies, sorted by proximity — each links to its official registry page
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma
Phase 2
Interventional 396 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: NRG Oncology
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Nephrology Physicians - Mishawaka — Mishawaka, Indiana (10.3 mi)
· Sponsor: Boehringer Ingelheim
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: SWOG Cancer Research Network
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Midwest Cardiovascular Research And Education Foundation — Elkhart, Indiana (1.0 mi)
· Sponsor: Amgen
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Digestive Research Alliance of Michiana — South Bend, Indiana (14.8 mi)
· Sponsor: Boehringer Ingelheim
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Respiratory Distress Syndrome, Pre-term Infants
Phase 3
Interventional 520 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi)
· Sponsor: Aerogen Pharma Limited
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity
Phase 2
Interventional 338 participants sought
Memorial Hospital of South Bend — South Bend, Indiana (14.8 mi)
· Sponsor: OHB Neonatology Ltd.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: NRG Oncology
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — South Bend, Indiana (14.8 mi)
· Sponsor: 89bio, Inc.
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Goshen Center for Cancer Care — Goshen, Indiana (10.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Hypertriglyceridemia
Phase 3
Interventional 869 participants sought
Research Site 43 — Elkhart, Indiana (1.0 mi)
· Sponsor: Arrowhead Pharmaceuticals
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Elkhart General Hospital — Elkhart, Indiana (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: SWOG Cancer Research Network
Persona Revision Knee System Outcomes
Arthroplasty Complications, Infection
N/A
Observational 380 participants sought
Jeff Yergler, LLC — Granger, Indiana (8.8 mi)
· Sponsor: Zimmer Biomet
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — Elkhart, Indiana (1.0 mi)
· Sponsor: AstraZeneca
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Corewell Health Lakeland Hospitals - Niles Hospital — Niles, Michigan (17.8 mi)
· Sponsor: NRG Oncology
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Areata Alopecia, Alopecia
Phase 3
Interventional 595 participants sought
The South Bend Clinic Center for Research — South Bend, Indiana (14.8 mi)
· Sponsor: Eli Lilly and Company
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Midwest Cardiovascular Research and Education Foundation — Elkhart, Indiana (1.0 mi)
· Sponsor: Boehringer Ingelheim